| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |